Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis

[Figure: see text].

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation research 2021-05, Vol.128 (11), p.1616-1625
Hauptverfasser:	Dörr, Katharina, Kammer, Michael, Reindl-Schwaighofer, Roman, Lorenz, Matthias, Prikoszovich, Thomas, Marculescu, Rodrig, Beitzke, Dietrich, Wielandner, Alice, Erben, Reinhold G., Oberbauer, Rainer
Format:	Artikel
Sprache:	eng
Schlagworte:	Death, Sudden, Cardiac - prevention & control Disease Progression Female Fibroblast Growth Factor-23 - blood Humans Hydroxycholecalciferols - administration & dosage Hydroxycholecalciferols - adverse effects Hydroxycholecalciferols - therapeutic use Hyperparathyroidism, Secondary - blood Hyperparathyroidism, Secondary - etiology Hypertrophy, Left Ventricular - blood Hypertrophy, Left Ventricular - diagnostic imaging Hypertrophy, Left Ventricular - drug therapy Hypertrophy, Left Ventricular - etiology Hypocalcemia - chemically induced Intention to Treat Analysis Klotho Proteins - blood Magnetic Resonance Imaging Male Middle Aged Parathyroid Hormone - blood Peptides - administration & dosage Peptides - adverse effects Peptides - therapeutic use Phosphates - blood Renal Dialysis Renal Insufficiency, Chronic - blood Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - therapy Single-Blind Method
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!